Pediatric patients with rare diseases deserve compassionate care and innovative treatments. Decentralized clinical trials offer hope. Learn execution strategies and more in our checklist: https://lnkd.in/eygd38w5 #DCTstrategies #DecentralizedClinicalTrials #RareDiseaseTrials #RareDiseases #PediatricTrials #PediatricRareDisease
Premier Research’s Post
More Relevant Posts
-
🔬 New findings from a PCORI-funded study on Kawasaki disease treatment are now available. This pivotal research compares two second-line treatments for children with resistant KD and their impact on coronary artery health. A must-read for medical professionals and healthcare executives involved in pediatric research and treatment strategies. Explore the comprehensive study here: https://pcori.me/3VNlp1s #HealthcareInnovation #PediatricResearch
To view or add a comment, sign in
-
HCPs: Pertussis cases are increasing. Infants may not have classic pertussis symptoms but instead present with apnea and minimal to no cough. Consider pertussis as a diagnosis in your pediatric patients. View the clinical course of pertussis: https://bit.ly/2Z8nPsH
To view or add a comment, sign in
-
Traditional clinical trial models often pose significant challenges for fragile populations, like children or those with chronic conditions, due to burdensome travel to and from the trial site. Mobile visits address this barrier by bringing trials directly to patients, easing family burdens and boosting enrollment and retention across diverse groups. Learn more about how mobile visits increase enrollment efficiency in pediatric clinical trials here: https://lnkd.in/dpfBKCHZ #PediatricClinicalTrials #MobileVisits #PatientEngagement
What patient populations are most appropriate for mobile visits?
To view or add a comment, sign in
-
Lets celebrate the colors!🎉🥂 today it’s my 3rd Rare Disease Day I celebrate-when I was 20weeks pregnant the USG showed that my baby has CDH…and thats where our way started…🚑🔬💊🩺🧬💉🧪Please,think about all patients that struggle with different diseases about which most of us even hasn’t heard of…thanks God that there is continuous research, great scientists and many clinical trials that make the medicine and doctors capable of doing almost miracles❤️🙏🏻 #rarediseaseday #rarediseases #cdh #cdhinternational #clinicalresearch #clinicaltrials #medicine #science #scientists #patients #patientcentricity #doctors #miracles
To view or add a comment, sign in
-
Over the past decade, there's been a notable surge in anticoagulation therapies for pediatric patients, with up to 15% of hospitalized children benefiting from #heparin or heparinoids. Frequent monitoring of Anti Factor Xa activity (aFXa) is crucial for children on heparin therapy, sometimes up to 2-3 times per day, to maintain therapeutic levels. However, current tests often require large blood volumes, posing a risk of iatrogenic anemia in neonates. Read this interesting blog on the "Unique Challenges to Heparin Monitoring in Neonatal and Pediatric Populations" and how Baebies' #DigitalMicrofluidics (#DMF) technology is addressing this challenge using only ~50 µL whole blood input with ~14 minutes time to result. Such a test would enable pediatric heparin therapy management, providing clinicians with timely data. Link: https://lnkd.in/gV4qvQEz #AnytestAnywhereEveryone #Heparin
To view or add a comment, sign in
-
It's Patient Experience #PXWeek! In less than a year Valley Health System reduced chair time, improved #PatientExperience, and increased staff efficiency in pediatric gastroenterology. Read our success story to find out how: https://hubs.ly/Q02vqGGd0 #Expanse #HealthIT #PEW2024 #PatExp
To view or add a comment, sign in
-
Explore a study investigating a therapeutic agent for the treatment of hyperphagia in patients 4 years and older with Prader-Willi Syndrome (PWS). Download the new #CaseStudy to discover effective solutions for successful recruitment and retention in a pediatric patient population: https://lnkd.in/gxQXdhae
To view or add a comment, sign in
-
Long-term neurobehavioral & functional outcomes of pediatric #ECMO survivors ➡️ most of patients with impaired function at discharge experience ongoing functional recovery at follow-up but pediatric ECMO survivors have, on average, mild neurobehavioral impairment related to adaptive functioning persisting years after decannulation ➡️ children who receive #ECPR, experience seizures while on #ECLS, have congenital heart disease or pre-ECMO developmental delay, or demonstrate feeding dysfunction at hospital discharge may be at the highest risk of long-term impaired function ASAIO Journal #PedsICU 🔓 https://bit.ly/3TXM9gd
To view or add a comment, sign in
-
MediWound's NexoBrid has demonstrated impressive safety and efficacy results in the NEXT (NexoBrid Expanded Access Treatment) protocol, further validating its potential as a ground-breaking treatment for severe thermal burns. Here are the key highlights: NexoBrid achieved complete debridement in 94.9% of adults and 100% of children treated, consistent with previous Phase 3 study results. This high success rate in eschar removal was accomplished with minimal need for additional surgical intervention - only 4.2% of adults required surgical excision after NexoBrid treatment, and none in the pediatric group. The treatment proved rapid and effective, with complete eschar removal occurring in less than one day for both adults and children. On average, only 3.6% of the wound area required surgical excision in adults, while no excision was needed for children. Regarding healing and hospitalization, the median time to wound closure was 22 days for adults and 28 days for children, with both groups having a median hospital stay of 10 days. These results from the NEXT protocol, conducted across 29 U.S. burn centers with 239 patients, reinforce NexoBrid's potential to revolutionize burn care by reducing the need for surgical interventions and improving patient outcomes. The data aligns with previous clinical trials, strengthening the case for NexoBrid's inclusion in standard burn care protocols. https://lnkd.in/g63Krq2G Stay informed and ahead of the curve by following Practical Patient Care on LinkedIn for the latest industry news and insights! #PracticalPatientCare #Woundcare #BurnCare #MedicalInnovation #ClinicalResearch #RegenerativeMedicine
To view or add a comment, sign in
-
Enfermera especialista en Estomaterapia/ Magister en enfermería, Candidata a Doctor Universidad de São Paulo, Docente universitaria.
Interesting session about IAD!!!!
It's time to consider the latest state-of-art and science of incontinence associated dermatitis. Get ready for this exciting #EPUAP2024 key session featuring talks by these distinguished speakers: 🗣 Dimitri Beeckman: Exploring contemporary perspectives on the diagnosis, differential diagnosis, and classification of incontinence-associated dermatitis 🗣 Jan Kottner: Prevention of incontinence-associated dermatitis in adults: The state of the science 🗣 Anna-Barbara Schlüer: IAD in pediatric care - Time for a new understanding Join us in September in Lausanne and attend this much needed session. The registration is open! bit.ly/EPUAP24_register #EPUAP #Lausanne #pressureulcers #stopthepressure #IAD #incontinence #dermatitis
To view or add a comment, sign in
124,750 followers